What clinical trials are currently recruiting in Texas?

TrialFinder lists 5031 recruiting clinical trials with sites in or near Texas. Results cover a wide range of conditions and are updated regularly from ClinicalTrials.gov.

Do I need insurance to join a clinical trial in Texas?

No. Study-related care is covered by the trial sponsor at no cost to participants. This includes the experimental treatment, required lab tests, and study visits. Many trials also provide compensation for time and travel. Health insurance is not required to search or enroll.

What conditions have clinical trials recruiting in Texas?

Trials in Texas cover a broad range of conditions including cancer, diabetes, heart disease, neurological disorders, autoimmune diseases, mental health conditions, and more. Use TrialFinder to search by specific condition and location.

How do I sign up for a clinical trial in Texas?

Find a trial that matches your condition on TrialFinder, review the eligibility criteria, and contact the research site listed on the trial detail page. Most research teams will conduct a brief phone pre-screening before any in-person visit. You can also create a free TrialFinder profile to get matched to recruiting trials near you.

5031 Recruiting Trials

Clinical Trials in Texas

Browse 5031 recruiting clinical trials currently enrolling participants in Texas. Search by condition to find trials you may qualify for — at no cost.

Showing 15 of 5031 recruiting trials in Texas

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

PHASE2 Birmingham, Alabama +4 sites · Multiple Myeloma, Advanced Solid Tumors

Recruiting

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

NA San Antonio, Texas · Diabetes Mellitus, Type 2, Impaired Glucose Tolerance (IGT)

Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

PHASE2 Birmingham, Alabama +4 sites · Sarcomatoid Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8

Recruiting

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

N/A Birmingham, Alabama +4 sites · Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation

Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

PHASE3 Anchorage, Alaska +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8

Recruiting

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

PHASE3 Birmingham, Alabama +4 sites · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Recruiting

Hydrus® Microstent New Enrollment Post-Approval Study

NA Irvine, California +4 sites · Primary Open Angle Glaucoma

Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

PHASE2 Birmingham, Alabama +4 sites · Wilms Tumor, Osteosarcoma

Recruiting

Electrophysiologic Sleep Phenotyping and Sleep-Dependent Neuro-maturation in Clinical and Healthy Pediatric Populations

N/A Bethesda, Maryland +4 sites · Healthy Children, Children With Neurodevelopmental Disorders

Recruiting

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

PHASE3 San Francisco, California +4 sites · Crohn's Disease, Inflammatory Bowel Diseases

Recruiting

Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

PHASE1 Los Angeles, California +4 sites · Advanced Solid Tumor

Recruiting

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

PHASE2 Los Angeles, California +4 sites · Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease

Recruiting

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

PHASE1 Indianapolis, Indiana +4 sites · Myeloid Leukemia, Philadelphia Positive

Recruiting

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

PHASE3 Birmingham, Alabama +4 sites · Non Small Cell Lung Cancer

Recruiting

Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

PHASE2 Phoenix, Arizona +4 sites · Peritoneal Malignant Mesothelioma

Recruiting

See all 5031 results in Texas

Check Your Eligibility

Create a free profile and our AI will match you to trials in Texas you may qualify for.

Get Matched — Free

No insurance required

Search by Condition in Texas

Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19

Browse Other States

California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon